BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28247290)

  • 1. Determination of non-Vitamin K oral anticoagulant (NOAC) effects using a new-generation thrombelastography TEG 6s system.
    Bliden KP; Chaudhary R; Mohammed N; Muresan AA; Lopez-Espina CG; Cohen E; Raviv G; Doubleday M; Zaman F; Mathew B; Tantry US; Gurbel PA
    J Thromb Thrombolysis; 2017 May; 43(4):437-445. PubMed ID: 28247290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Thromboelastography (TEG) for Detection of New Oral Anticoagulants.
    Dias JD; Norem K; Doorneweerd DD; Thurer RL; Popovsky MA; Omert LA
    Arch Pathol Lab Med; 2015 May; 139(5):665-73. PubMed ID: 25927150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing of NOACs has outnumbered warfarin: exploring how physicians choose anticoagulant treatments.
    Eek AK; Øie E; Granas AG
    Eur J Clin Pharmacol; 2018 Mar; 74(3):323-330. PubMed ID: 29149366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 5000.
    Artang R; Brod C; Nielsen JD
    Semin Thromb Hemost; 2022 Oct; 48(7):808-813. PubMed ID: 36174600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A Review.
    Eikelboom JW; Quinlan DJ; Hirsh J; Connolly SJ; Weitz JI
    JAMA Cardiol; 2017 May; 2(5):566-574. PubMed ID: 28355459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
    Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
    Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New - direct oral anticoagulants: actual review].
    Michalcová J; Penka M; Buliková A; Zavřelová J; Štěpařová A
    Vnitr Lek; 2016; 62(10):805-813. PubMed ID: 27900867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid point-of-care detection and classification of direct-acting oral anticoagulants with the TEG 6s: Implications for trauma and acute care surgery.
    Dias JD; Lopez-Espina CG; Ippolito J; Hsiao LH; Zaman F; Muresan AA; Thomas SG; Walsh M; Jones AJ; Grisoli A; Thurston BC; Artang R; Bilden KP; Hartmann J; Achneck HE
    J Trauma Acute Care Surg; 2019 Aug; 87(2):364-370. PubMed ID: 31045726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point-of-Care Testing of Coagulation in Patients Treated With Non-Vitamin K Antagonist Oral Anticoagulants.
    Ebner M; Peter A; Spencer C; Härtig F; Birschmann I; Kuhn J; Wolf M; Winter N; Russo F; Zuern CS; Blumenstock G; Ziemann U; Poli S
    Stroke; 2015 Oct; 46(10):2741-7. PubMed ID: 26272385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anticoagulant effect of therapeutic levels of dabigatran in atrial fibrillation evaluated by thrombelastography (TEG
    Solbeck S; Jensen AS; Maschmann C; Stensballe J; Ostrowski SR; Johansson PI
    Scand J Clin Lab Invest; 2018; 78(1-2):25-30. PubMed ID: 29304563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct Comparison of Dabigatran, Rivaroxaban, and Apixaban for Effectiveness and Safety in Nonvalvular Atrial Fibrillation.
    Noseworthy PA; Yao X; Abraham NS; Sangaralingham LR; McBane RD; Shah ND
    Chest; 2016 Dec; 150(6):1302-1312. PubMed ID: 27938741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non-vitamin K dependent oral anticoagulants : What is important in intensive care medicine].
    Gulba DC; Broscaru L
    Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):83-91. PubMed ID: 28144727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.
    Stöllberger C; Finsterer J
    Herz; 2015 Apr; 40 Suppl 2():140-5. PubMed ID: 25616425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.
    Pernod G; Albaladejo P; Godier A; Samama CM; Susen S; Gruel Y; Blais N; Fontana P; Cohen A; Llau JV; Rosencher N; Schved JF; de Maistre E; Samama MM; Mismetti P; Sié P;
    Arch Cardiovasc Dis; 2013; 106(6-7):382-93. PubMed ID: 23810130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
    Jin C; Huang RJ; Peterson ED; Laskowitz DT; Hernandez AF; Federspiel JJ; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Xian Y
    Stroke; 2018 Sep; 49(9):2237-2240. PubMed ID: 30354981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multianalyte Determination of NOACs Using LC-MS/MS and Comparison with Functional Coagulation Assays.
    Slavik L; Lukes J; Friedecky D; Zhanelova M; Nemcova M; Ulehlova J; Prochazkova J; Hlusi A; Palova M; Vaclavik J
    Clin Lab; 2018 Oct; 64(10):1611-1621. PubMed ID: 30336535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers.
    Artang R; Anderson M; Nielsen JD
    Res Pract Thromb Haemost; 2019 Jul; 3(3):391-396. PubMed ID: 31294326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care testing for emergency assessment of coagulation in patients treated with direct oral anticoagulants.
    Ebner M; Birschmann I; Peter A; Spencer C; Härtig F; Kuhn J; Blumenstock G; Zuern CS; Ziemann U; Poli S
    Crit Care; 2017 Feb; 21(1):32. PubMed ID: 28196509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic coagulation assay for monitoring anticoagulant therapy in acute stroke patients.
    Bluecher A; Meyer Dos Santos S; Ferreirós N; Labocha S; Meyer Dos Santos IM; Picard-Willems B; Harder S; Singer OC
    Thromb Haemost; 2017 Feb; 117(3):519-528. PubMed ID: 28124061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate.
    Dinkelaar J; Patiwael S; Harenberg J; Leyte A; Brinkman HJ
    Clin Chem Lab Med; 2014 Nov; 52(11):1615-23. PubMed ID: 24902009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.